Proteins for Serological Test of COVID-19
- Field
- Diagnostics
- Reference No.
- IP00951
Key Problem and Market Opportunity
- Coronavirus disease (COVID-19) pandemic has caused more than 330,000 death and serious health problem world-wide
- Early detection of the infection is important
- Population immunity needs to check accurately
- Quick detection method for cases with early infection and population-wide screening for immunity is needed
- Cross-reactivity of antibody in the present commercially available detection methods is a problem
Key Advantages of the Technology
- Unique novel targets to SARS-CoV-2
- Clearly distinguish between infected cases and normal control when compared with Protein S
- Make use of luciferase immunoprecipitation system
Potential Product and Services
Applications
- Various types of immunoassay for hospitals and clinics
- A dip stick to provide quick test for population screening
Opportunity
- Prepared for international applications
- Require small pilot batch for testing
Development Status
Patents
- Filed US provisional application
IP Status
- Patent application submitted
Seeking
- Development partner